BioArctic's partner Eisai presents sales simulation of potential future sales of Leqembi® at its Investor Relations Day

STOCKHOLM, May 25, 2026 /PRNewswire/ -- BioArctic AB's (publ) (NASDAQ Stockholm: BIOA B) partner Eisai today published a presentation including a simulation[1] of potential future sales for Leqembi. According to Eisai's simulation, Leqembi sales will reach around JPY 300 billion...